Overview

Prophylactic Treatment With Oseltamivir

Status:
Completed
Trial end date:
2020-03-31
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to compare the efficacy of 5-day versus 10-day oseltamivir prophylactic treatment in patients who had been exposed to influenza.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University Medical Centre Ljubljana
Treatments:
Oseltamivir
Criteria
Inclusion Criteria:

- 18 years or older

- exposure to influenza during hospitalization

- risk factors for influenza complications

- consent for participation obtained

Exclusion Criteria:

- younger than 18 years

- hematological malignancy

- hospitalized in intensive care unit

- refusal to participate